Revues de langue anglaise
Iordache L, Launay O, Bouchaud O, Jeantils V, Goujard C, Boue F, Cacoub P, Hanslik T, Mahr A, Lambotte O, Fain O. Autoimmune diseases in HIV-Infected patients: 52 cases and literature review. Autoimmunity Reviews 2014;13(8):850-857
van Essen, Beran J, Devaster JM, Durand C, Duval X, Esen M, Falsey AR, Feldman G, Gervais P, Innis BL, Kovac M, Launay O, Leroux-Roels G, McElhaney JE, McNeil S, Oujaa M, Richardus JH, Ruiz-Palacios G, Osborne RH, Oostvogels L. Influenza symptoms and their impact on elderly adults: randomised trial of AS03-adjuvanted or non-adjuvanted inactivated trivalent seasonal influenza vaccines. Influenza and other Respiratory viruses 2014; 8(4): 452-462
Launay O, Le Strat Y, Tosini W, Kara L, Quelet S, Lévy S, Danan J, Réveillon J, Houdayer J, Bouvet E, Lévy-Bruhl D; The ANRS-FORMVAC Study Group. Impact of free on-site vaccine and/or healthcare workers training on hepatitis B vaccination acceptability in high-risk subjects: a pre-post cluster randomized study. Clin Microbiol Infect. 2014 May 22. doi: 10.1111/1469-0691.12689. [Epub ahead of print]
Launay O, Boelle PY, Krivine A, Grenet D, Boussaud V, Rémus N, Corvol H, Chedevergne F, Hubert D, Sermet-Gaudelus I; Inserm MUCOFLU group. Factors associated with humoral immune response to pandemic A/H1N1(v) 2009 influenza vaccine in cystic fibrosis. Vaccine. 2014 Jun 17 [Epub ahead of print]
Puig-Barberà J, Natividad-Sancho A, Launay O, Burtseva E, Ciblak MA, Tormos A, Buigues-Vila A, Martínez-Úbeda S, Sominina A; the GIHSN Group. 2012-2013 Seasonal Influenza Vaccine Effectiveness against Influenza Hospitalizations: Results from the Global Influenza Hospital Surveillance Network. PLoS One. 2014 Jun 19;9(6):e100497
Zhang X, Mozeleski B, Lemoine S, Dériaud E, Lim A, Zhivaki D, Azria E, Le Ray C, Roguet G, Launay O, Vanet A, Leclerc C, Lo-Man R. CD4 T cells with effector memory phenotype and function develop in the sterile environment of the fetus. Sci Transl Med. 2014 May 28;6(238)
Launay O, Le Strat Y, Tosini W, Kara L, Quelet S, Lévy S, Danan J, Réveillon J, Houdayer J, Bouvet E, Lévy-Bruhl D; The ANRS-FORMVAC Study Group.Impact of free on-site vaccine and/or healthcare workers training on hepatitis B vaccination acceptability in high-risk subjects: A pre-post cluster randomized study. Clin Microbiol Infect. 2014 May 22. [Epub ahead of print]
Kerneis S, Launay O, Turbelin C, Batteux F, Hanslik T, Boelle PY. Long term Immune Responses to Vaccination in HIV-Infected Patients: A Systematic Review and Meta-Analysis. Clinical Infectious Diseases 2014;58(8):1130-1139
Desaint C, Durier C, Poda A, Krivine A, Simon F, Bodilis H, Pialoux G, Cuzin L, Poizot-Martin I, Morineau P, Lelievre JD, Silbermann B, Aboulker JP and Launay O. Long-Term Persistence of Vaccine-Induced HIV Seropositivity in Healthy Volunteers. J AIDS Clin Res 2014,5:275.
Zhang X, Casartelli N, Lemoine S, Mozeleski B, Azria E, Le Ray C, Schwartz O, Launay O, Leclerc C, Lo-Man R. Plasmacytoid Dendritic Cells Engagement by Influenza Vaccine as a Surrogate Stategy for Driving T-Helper Type 1 Responses in Human Neonatal Settings. J Infect Dis. 2014 Mar 21. [Epub ahead of print]
Falsey AR, McElhaney JE, Beran J, van Essen GA, Duval X, Esen M, Galtier F, Gervais P, Hwang SJ, Kremsner P, Launay O, Leroux-Roels G, McNeil SA, Nowakowski A, Richardus JH, Ruiz-Palacios G, St Rose S, Devaster JM, Oostvogels L, Durviaux S, Taylor S. Respiratory Syncytial Virus and Other Respiratory Viral Infections in Older Adults With Moderate to Severe Influenza-like Illness. J Infect Dis. 2014 Jan 29. [Epub ahead of print]
Loulergue P, Launay O.Vaccinations among medical and nursing students: Coverage and opportunities. Vaccine. 2014 Feb 4.[Epub ahead of print]
N'Diaye DS, Yazdanpanah Y, Krivine A, Andrieu T, Rozenberg F, Picone O, Tsatsaris V, Goffinet F, Launay O. Predictive factors of cytomegalovirus seropositivity among pregnant women in Paris, France.
PLoS One. 2014 Feb 24;9(2)
Loison E, Poirier-Beaudouin B, Seffer V, Paoletti A, Abitbol V, Tartour E, Launay O, Gougeon ML. Suppression by thimerosal of ex-vivo CD4+T cell response to influenza vaccine and induction of apoptosis in primary memory T cells. PLoS One. 2014 Apr 1;9(4)
Wyplosz B, Burdet C, François H, Durrbach A, Duclos-Vallée JC, Mamzer-Bruneel MF, Poujol P, Launay O, Samuel D, Vittecoq D and Consigny PH for the GEVACCIM. Persistence of Yellow Fever Vaccine-Induced Antibodies After Solid Organ Transplantation. American Journal of Transplantation 2013;13:2458-2461
Launay O, Duval X, Fitoussi S, Jilg W, Kerdpanich A, Montellano M, Schwaz Tino F, Watanveerade V, Wenzel Jürgen J, Zalcman G, Bambure V, Li P, Caplanusi A, Madan A, Gillard P and Vaughn David W. Extended antigen sparing potential of AS03-adjuvanted pandemic H1N1 vaccines in children, and immunological equivalence of two formulations of AS03-adjuvanted H1N1vaccines: results from towo randomised trials. BMC Infectious Diseases 2013;13:435
Pilorgé L, Chartier M, Méritet JF, Cervantes M, Tsatsaris V, Launay O, Rozenberg F, Krivine A. Rhinoviruses as an Underestimated Cause of Influenza-Like Illness in Pregnancy During the 2009-2010 Influenza Pandemic. Journal of Medical Virology 2013, 85(8);1473-7
Loulergue P, Fonteneau L, Armengaud JB, Momcilovic S, Levy-Brühl D, Launay O, Guthmann JP, for the Studyvax survey group. Vaccine coverage of healthcare students working in hospitals of the Paris region, 2009: the STUDYVAX survey. Vaccine 2013; 10;31(26):2835-8
Launay O, Paul S, Servettaz A, Roguet G, Rozenberg F, Lucht F, Lambert C, Presles E, Goulvestre C, Méritet JF, Galtier F, Dubray C, Lebon P, Weill B, Batteux F. Control of humoral immunity and auto-immunity by the CXCR4/CXC.12 axis in lupus patients following influenza vaccine. Vaccine 2013; (31), 3492-3401
Kernéis S, Launay O, Ancelle T, Iordache L, Naneix-Laroche V, Naneix-Laroche V, Méchaï F, Fehr T, Leroy JP, Issartel B, Dunand J, Van Der Vliet D, Wyplosz B, Consigny PH, Hanslik T. Safety and Immunogenicity of Yellow Fever 17D Vaccine in Adults Receiving Systemic Corticosteroid Therapy: An Observational Cohort Study. Arthritis Care & Research 2013; (65), 1522-1528
Launay O, Surenaud M, Desaint C, Ben Hamouda N, Pialoux G, Bonnet B, Poizot Martin I, Gonzales G, Cuzin L, Bourgault Villada I, Lévy Y, Choppin J, Durier C. Long-term CD4+ and CD8+ T-cell responses induced in HIV-uninfected volunteers following intradermal or intramuscular administration of an HIV-lipopeptide vaccine (ANRS VAC 16). Vaccine 2013; 31, 4406-4415
Bonduelle O, Yahia N, Siberil S, Benhabiles N, Carrat F, Krivine A, Rozenberg F, Dimitrov J, Kaveri S, Curjol A, Tindel M, Louet M, Desert F, Launay O, Loulergue P, Badre G, Katlama C, Bricaire F, Samri A, Rousset D, Van der Werf S, Jauréguiberry S, Combadière B.
Longitudinal and Intergrative Biomodeling of Effector and Memory Immune Compartments after Inactivated Influenza Vaccination
The Journal of Immunology 2013;191(2):623-31
Launay O, Paul S, Servettaz A, Roguet G, Rozenberg F, Lucht F, Lambert C, Presles E, Goulvestre C, Meritet JF, Galtier F, Dubray C, Lebon P, Weill B, Batteux F.
Control of humoral immunity and auto-immunity by the CXCR4/CXCL12 axis in lupus patients following influenza vaccine
Vaccine 2013 2;31(35)
Durier C, Desaint C, Lucht F, Girard PM, Levy Y, May T, Michelet C, Rami A, Roman F, Delfraissy JF, Aboulker JP, Launay O.
Long-term immunogenicity of two doses of 2009 A/H1N1v vaccine with and without AS03(A) adjuvant in HIV-1-infected adults.
AIDS 2013;27(1), 87-93
Zhang XM, Lepelley A, Azria E, Lebon P, Roguet G, Schwartz O, Launay O, Leclerc C, Lo-Man R
Neonatal Plasmacytoid Dendritic Cells (pDCs) Display Subset Variation But Can Elicit Potent Anti-Viral Innate Responses
Plos One 2013;8(1) e52003
Rondy M, Puig-Barbera J, Launay O, Duval S, Castilla J, Guevara M, Costanzo S, Donati KD, Moren A.
2011-12 Seasonal Influenza Vaccines Effectiveness against Confirmed A(H3N2) Influenza Hospitalisation: Pooled Analysis from a European Network of Hospitals. A Pilot Study
Plos One 2013;8(4) e59681
Launay O, Duval X, Fitoussi S, Jilg W, Kerdpanich A, Montellano M, Schwarz TF, Watanveerade V, Wenzel JJ, Zalcman G, Bambure V, Li P, Caplanusi A, Madan A, Gillard P and Vaughn D W. Extended antigen sparing potential of AS03-adjuvanted pandemic H1N1 vaccines in children, and immunological equivalence of two formulations of AS03-adjuvanted H1N1 vaccines: results from two randomised trials. BMC Infectious Diseases 2013; 16,13(1):435
Laurichesse H, Zimmermann U, Galtier F, Launay O, Duval X, Richard P, Sadorge C, Soubeyrand B.
Immunogenicity and safety results from a randomized multicenter trial comparing a Tdap-IPV vaccine (REPEVAX ®) and a tetanus monovalent vaccine in healthy adults: New considerations for the management of patients with tetanus-prone injuries
Hum Vaccin Immunother. 2012. 2;8(12)
Duval X, Caplanusi A, Laurichesse H, Deplanque D, Loulergue P, Vaman T, Launay O, Gillard P.
Flexibility of interval between vaccinations with AS03(A)-adjuvanted influenza A(H1N1) 2009 vaccine in adults aged 18-60 and sup 60 years: a randomized trial
BMC Infectious Diseases 2012;12(162)
Launay O, Krivine A, Charlier C, Truster V, Tsatsaris V, Lepercq J, Ville Y, Avenell C, Andrieu T, Artiguebielle F, Treluyer Jm, Goffinet F.
Low Rate of Pandemic A/H1N1 2009 Influenza Infection and Lack of Severe Complication of Vaccination in Pregnant Women: A Prospective Cohort Study
Plos One 2012;7(12) e52303
Hosmalin A, Amraoui S, DeRosa AL, Jourdain JP, Vimeux L, Goujard C, Loulergue P, Launay O, Richard Y, Dutertre CA.
M-DC8+monocyte expansion and TNFa overproduction in response to LPS during HIV-1 infection
Immunology 2012;137(SI):519-519
Rousseau B, Loulergue P, Mir O, Krivine A, Kotti S, Viel E, Simon T, de Gramont A, Goldwasser F, Launay O, Tournigand C.
Immunogenicity and safety of the influenza A H1N1v2009 vaccine in cancer patients treated with cytotoxic chemotherapy and/or targeted therapy: the VACANCE study
Annals of Oncology 2012;23 (2),450-457
Durier C, Desaint C, Lucht F, Girard PM, Lévy Y, May T, Michelet C, Rami A, Roman F, Delfraissy JF, Aboulker JP, Launay O; for the ANRS 151 study group and the REIVAC network.
Long term immunogenicity of two doses of 2009A/h1N1v vaccine with and without AS03A-adjuvant in HIV-1-infected adults: ANRS 151 Randomized HIFLUVAC Trial.
AIDS 2012 Sep 26 [Epub ahead of print]
Rivière Y, Montange T, Janvier G, Marnata C, Durrieu L, Chaix ML, Isaguliants M, Launay O, Bresson JL and Pol S.
Hepatitis C virus-specific cellular immune responses in individuals with no evidence of infection
Virology Journal 2012, 9:76
Scotto M, Afonso G, Larger E, Raverdy C, Lemonnier FA, Carel JC, Dubois-Laforgue D, Baz B, Levy D, Gautier JF, Launay O, Bruno G, Boitard C, Sechi LA, Hutton JC, Davidson HW, Mallone R.
Zinc transporter (ZnT)8186-194 is an immunodominant CD8+ Tcell epitope in HLA-A2+ type 1 diabetic patients.
Diabetologia 2012; 55(7):2026-2031
Scotto M, Afonso G, Osterbye T, Larger E, Luce S, Raverdy C, Novelli G, Bruno G, Gonfroy-Leymarie C, Launay O, Lemaonnier FA, Buus S, Carel JC, Boitard C, Mallone R.
HLA-B7-Restricted Islet Epitopes Are Differentially Recognized in Type 1 Diabetic Children and Adults and Form Weak Peptide-HLA Complexes
Diabetes 2012; 61(10):2546-2555
Dutertre CA, Amraoui S, Derosa A, Jourdain JP, Vimeux L, Goguet M, Degrelle S, Feuillet V, Liovat AS, Müller-Trutwin M, Decroix N, Deveau C, Meyer L, Goujard C, Loulergue P, Launay O, Richard Y, Hosmalin A.
Pivotal role of M-DC8+ monocytes from viremic HIV-infected patients in TNFα overproduction in response to microbial products.
Blood 2012; 13,120(11):2259-68
Phung B-C, Launay O.
Vaccination against viral hepatitis of HIV-1 infected patients.
Hum Vaccin Immunother. 2012 1;8(5):554-9
D'Alessandro E, Hubert D, Launay O, Bassinet L, Lortholary O, Jaffre Y, Sermet-Gaudelus I.
Determinants of Refusal of A/H1N1 Pandemic Vaccination in a High Risk Population: A Qualitative Approach
PloS One. 2012;7(4)e34054
Chauvat A, Benhamouda N, Loison E, Gougeon ML, Gey A, Levionnois E, Ravel P, Abitbol V, Roncelin S, Marcheteau E, Quintin-Colonna F, Fridmann WH, Launay O, Tartour E.
Pitfalls in anti-influenza T cell detection by Elispot using thimerosal containing pandemic H1N1 vaccine as antigen
Journal of Immunological Methods 2012 Feb 16. [Epub ahead of print]
Tsatsaris V, Capitant C, Schmitz T, Chazallon C, Bulifon S, Riethmuller D, Picone O, Poulain P, Lewin F, Lainé F, Jacqz-Aigrain E, Aboulker JP, Launay O; for the Inserm C09-33 Prefluvac (Immunogenicyty and Safety of an Inactivated Nonadjuvanted A[H1N1v] Influenza Vaccine in Pregnant Women Study Group.
Maternal Immune Response and Neonatal Seroprotection From a Single Dose of a Monovalent Nonadjuvanted 2009 Influenza A(H1N1) Vaccine: A Single-Group Trial.
Ann Intern Med. 2011 Dec 6;155(11):733-741.
Loulergue P, Duval X, Galtier F, Lenzi N, Lauichesse H, Launay O.
Questions for Biotechs: REIVAC.
Hum Vaccin. 2011 Feb 1;7(2):142-3.
Launay O, Masurel J, Servant-Delmas A, Basse-Guérineau, Méritet JF, Laperche S, Sogni P, Rosenberg AR
High levels of serum hepatitis B virus DNA in patients with 'anti-HBc alone': role of HBsAg mutants
Journal of Viral Hepatitis, 2011, 18, 721-729.
Kernéis S, Desaint C, Brichler S, Rey D, Belarbi L, Gordien E, Pacanowski J, Lortholary O, Abgrall S, Boëlle PY, Grabar S, Launay O.
Long-Term Persistence of Humoral Immunity After Hepatitis A Vaccination in HIV-Infected Adults.
J. Acquir Immune Defic Syndr. 2011 Jul 1;57 (3):e63-e66
Freund R, Le Ray C, Charlier C, Avenell C, Truster V, Tréluyer JM, Skalli D, Ville Y, Goffinet F, Launay O, for the Inserm COFLUPREG Study Group.
Determinants of Non-Vaccination against Pandemic 2009 H1N1 Influenza in Pregnant Women: A Prospective Cohort Study
PloS ONE 2011June, Vol 6, Issue 6
Launay O, Desaint C, Durier C, Loulergue P, Duval X, Jacomet C, Pialoux G, Ghosn J, Raffi F, Rey D, Ajana F, Colin de Verdière N, Reynes J, Foubert V, Roman F, Deaster JM, Delfraissy JF, and Aboulker JP and for the ANRS 151 HIFLUVAC Study Group and the French Clinical Vaccinology Network (Réseau National d'Investigation Clinique en Vaccinologie REIVAC).
Safety and Immunogenicity of a Monovalent 2009 Influenza A/H1N1v Vaccine Adjuvanted With AS03A or Unadjuvanted in HIV-Infected Adults: A randomized, Controlled Trial.
JID 2011:204 (1July)
Rousseau B, Loulergue P, Mir O, Krivine A, Kotti S, Viel E, Simon T, de Gramont A, Goldwasser F, Launay O, Tournigand C.
Immunogenicity and safety of the influenza A H1N1v 2009 vaccine in cancer patients treated with cytotoxic chemotherapy and/or targeted therapy: the VACANCE study.
Annals of Oncology 2011May 16
Loulergue P, Alexandre J, Iurisci I, Grabar S, Medioni J, Ropert S, Dieras V, Le Chevalier F, Oudard S, Goldwasser F, Lebon P and Launay O.
Low immunogenicity of seasonal trivalent influenza vaccine among patients receiving docetaxel for a solid tumour: results of a prospective pilot study
British Journal of Cancer 2011, May 24;104(11):1670-4
Launay O, van der Vliet, D, Rosenberg A, Michel ML, Piroth L, Rey D, Colin de Verdière N, Slama L, Martin K, Lortholary O, Carrat F, for the ANRS HB03 VIHVAC-B Trial.
Safety and Immunogenicity of 4 Intramuscular Double Doses and 4 Intradermal Low Doses vs Standard Hepatitis B Vaccine Regimen in Adults With HIV1: A Randomized Controlled Trial
JAMA.2011;305(14):1432-1440
Marchand-Janssen, Loulergue P, Mouthon L, Mahr A, Blanche P, Deforges L, Lebon P, Cohen P, Pagnoux C, Le Guern V, Bienvenu B, Aouba A, Guillevin L, Launay O.
Patients with systemic inflammatory and autoimmune diseases are at risk of vaccine-preventable illnesses.
Rheumatology (Oxford). 2011 Jan 21. [Epub ahead of print]
Dubar G, Azria E, Tesnière A, Dupont H, Le Ray C, Baugnon T, Matheron S, Luton D, Richard JC, Launay O, Tsatsaris V, Goffinet F, Mignon A; French Registry on 2009 A/H1N1v during pregnancy
French experience of 2009 A/H1N1v influenza in pregnant women.
PLoS One. 2010 Oct 5;5(10). pii: e13112.
Launay O, Hoch D, Saint-Sardos C, Guillemot D; participates of Round Table n∞ 6 Giens XXV
Vaccines: specific features, simulation of impact and medico-economic modelling
Therapie. 2010 65(4):357-65, 347-55.
Cervantes-Gonzalez M, Launay O.
Pandemic influenza A (H1N1) in pregnant women: impact of early diagnosis and antiviral treatment
Expert Rev Anti Infect Ther. 2010:8(9);981-4.
Freire T, Zhang X, Dériaud E, Ganneau C, Vichier-Guerre S, Azria E, Launay O, Lo-Man R, Bay S, Leclerc C
Glycosidic Tn-based vaccines targeting dermal dendritic cells favor germinal center B-cell development and potent antibody response in the absence of adjuvant.
Blood. 2010 4;116(18):3526-36.
Cervantes-Gonzalez M, Launay O.
Term labor management and outcomes in treated HIV-infected women without contraindications to vaginal delivery and matched controls.
Int J Gynaecol Obstet. 2010
111(2):161-4.
P. Loulergue, P.R. Burgel, F. Carrat, B. Fritzell, J.P. Guthmann, C. Locht, U.F. Power, E. Varon, D. Dusser and O. Launay.
Report of the 2nd "French Clinical Vaccinology Meeting Jean-Gerard Guillet": Immunization and respiratory diseases.
Vaccine. 2010 Jul 29. (Epub ahead of print)
Salmon-Céron D, Durier D, Desaint C, Cuzin L, Surenaud M, Ben Hamouda N, Jackson A, Flys C, Hénin Y, Lelièvre JD, Bonnet B, Pialoux G, Poizot-Martin I, Guérin G, Alboulker JP, Choppin J, Lévy Y, Launay O; for the ANRS VAC 18 trial group.
Immunogenicity and safety of an HIV-1 lipopeptide vaccine in healthy adults: a phase 2 placebo-controlled ANRS trial.
AIDS 2010. Sep10;24(14):2211-23
Larnaudie S, Guiso N, Baptiste C, Desaint C, Deforges L, Lebon P, Soubeyrand B, Launay O.
Humoral immunity induced by REPEVAX (Tdap-IPV) vaccine administered 1 Month after REVAXIS (Tdp-IPV) Vaccine in Adults with Unknown Vaccination History.
Human Vaccine 2010, 1;6(10)
Mouthon L, Mestre C, Poiraudeau S, Berezné A, Marchand C, Guilpain P, Guillevin L, Launay O.
Low influenza vaccination rate among adults following for systemic sclerosis.
Rheumatology 2010; 49(3):600-6
Revues de langue française
Anselem O, Parat S, Theau A, Floret D, Tsatsaris V, Goffinet F, Launay O. Vaccination and pregnancy. Presse Medicale 2014; 43(6):715-721
Aubert M, Aumaître H, Beytout J, Bloch K, Bouhour D, Callamand P, Chave C, Cheymol J, Combadière B, Dahlab A, Denis F, De Pontual L, Dodet B, Dommergues MA, Dufour V, Gagneur A, Gaillat J, Gaudelus J, Gavazzi G, Gillet Y, Gras-le-Guen C, Haas H, Hanslik T, Hau-Rainsard I, Larnaudie S, Launay O, Lorrot M, Loulergue P, Malvy D, Marchand S, Picherot G, Pinquier D, Pulcini C, Rabaud C, Rengnier F, Reinert P, Sana C, Savagner C, Soubeyrand B, Stephan JL, Strady C.
Current events in vaccination.
Arch Pediatr. 2011 Nov;18(11):1234-46
Anselem O, Tsatsaris V, Lopez E, Krivine A, Le Ray C, Loulergue P, Floret D, Goffinet F, Launay O.
Measles and Pregnacy
Presse Med. 2011; 40:1001-1007
Duchet-Niedziolka P, Hanslik T, Mouthon L, Guillevin L, Launay O.
Flu vaccine and auto-immune and/or inflammatory diseases.
Presse Med. 2011 Jan 11[Epub ahead of print]
Aubert M, Aumaître H, Beytout J, Bloch K, Bouhour D, Callamand P, Chave C, Cheymol J, Combadière B, Dahlab A, Denis F, De Pontual L, Dodet B, Dommergues MA, Dufour V, Gagneur A, Gaillat J, Gaudelus J, Gavazzi G, Gillet Y, Gras-le-Guen C, Haas H, Hanslik T, Hau-Rainsard I, Larnaudie S, Launay O, Lorrot M, Loulergue P, Malvy D, Marchand S, Picherot G, Pinquier D, Pulcini C, Rabaud C, Regnier F, Reinert P, Sana C, Savagner C, Soubeyrand B, Stephan JL, Strady C.
Current events in vaccination.
Med Mal Infect. 2011 Apr 12. [Epub ahead of print]
Group Avancées Vaccinales, Gaillat J.
Collaborators : Ajana F, Alain S, Angelin-Duclos C, Aumaitre H, Bregere P, Launay O, Parez N, Rogeaux O, Soubeyrand B, Strady C, Weil-Olivier C.
Impact of childhood immunization programs in 20th century France
Rev Prat. 2010 Oct 20;60(8):1044-8
Launay O
New Influenza A H1N1v: usefulness of immunization
Presse Med. 2010 39(1):6-9.
Launay O, Hoch D, Saint-Sardos C, Guillemot D. and participants of Round Table n∞6 of Giens XXV.
Vaccines: Specific Features, Simulation of Impact and Medico-Economic Modelling
Therapie 2010; Juillet-Ao˚t;65(4):357-365 (Epub 2010 Sep 21).
Charlier C, Launay O, Coignard-Biehler H, Lecuit M, Lortholary O
Pregnancy: a high risk factor in influenza infection.
Med Sci (Paris). 2010 26(1):100-4.
Bulifon S, Tsatsaris V, Goffinet F, Mignon A, Batteux F, Delfraissy JF, Launay O.
Pandémie Grippale A/H1N1v, Grossesse et Vaccination.
Med Mal Infect. 2010; Sep 8 (Epub ahead of print)
Yvette Hénin, Bénédicte de Boischevalier, Françoise Reboul-Salze, Jean-Luc Cracowski et Christian Dualé pour le Groupe de Travail "Ethique" du Réseau National des Centres d'Investigation Clinique.
Aide à la rédaction du document écrit destiné à l'information du participant à la Recherche BioMédicale et à l'attestation de son consentement éclairé.
Therapie 2010; Mars-Avril 2010; 65(2):71-94
Dubar G, Launay O, Batteux F, Tsatsaris V, Goffinet F, Mignon A.
Pregnancy and pandemic influenza A(H1N1) 2009. Current concepts for anaesthesia and critical care medicine.
Ann Fr Anesth Reanim 2010.Feb;29(2):126-34
Un site de 1001sitesweb - © Copyright CIC de Vaccinologie Cochin Pasteur 2010 - 2014
Page lue en 0,0102 seconde (6/0)